Evidence map›Paper›PMID 34653748›Full record

ArticleCancer treatment and research communications2021

Supportive care in multiple myeloma: Current practices and advances.

Teresa S Miceli, Wilson I Gonsalves, Francis K Buadi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer treatment and research communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Thromboprophylaxis in multiple myeloma.Research and practice in thrombosis and haemostasis · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Evolving progress in the management of malignant plasma cell disorders.Cancer treatment and research communications · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Teresa S MiceliDivision of Hematology, Mayo Clinic Rochester, United States.
Wilson I GonsalvesDivision of Hematology, Mayo Clinic Rochester, United States. Electronic address: gonsalves.wilson@mayo.edu.
Francis K BuadiDivision of Hematology, Mayo Clinic Rochester, United States. Electronic address: buadi.francis@mayo.edu.
Mayo Clinic · USWinnMed · US

Funding

Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple MyelomaP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Peter Leif Bergsagel · 2015 to 2026
$25.5M
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal GammopathiesR01CA254961 · NCI · MAYO CLINIC ROCHESTER · PI GONSALVES, WILSON · 2021 to 2024
$1.5M
NCI NIH HHS P50 CA186781NCI NIH HHS R01 CA254961
6 · The paper itself

Abstract

Supportive care in multiple myeloma (MM) can have a major impact on quality of life and the survival outcomes of MM patients. In this review, we will focus on disease and treatment related toxicities experienced by MM patients and what are the best approaches to date to help mitigate the effects. We will specifically focus on a practical approach to managing bone disease, thrombosis, infection risk, peripheral neuropathy, dermatologic complications, gastrointestinal and ocular toxicities, and fatigue in MM.

Indexed as

HumansMultiple MyelomaPalliative CareQuality of LifeMultiple myelomaQuality of lifeSupportive care

Identifiers

PMID34653748
PMCPMC8688260
OpenAlexW3207872016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.